Speech-Language Pathologists in Louisville, KY Accepting Medicare
602 Speech-Language Pathologists found. Showing 141 - 160
 Danielle Shay Cooling Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 303 N Hurstbourne Pkwy Ste 200, Louisville, KY 40222 Phone: 502-412-5847 |
Kaelyn Noelle Spowart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 Neville Dr, Louisville, KY 40216 Phone: 502-633-1007 |
Morgan Messina Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1550 Raydale Dr, Louisville, KY 40219 Phone: 502-968-6600 |
Katrina Lee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3324 Frontier Trail, Louisville, KY 40220 Phone: 502-435-6316 |
Mrs. Jennifer Michele Belcher, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9810 Bluegrass Pkwy, Louisville, KY 40299 Phone: 502-418-7787 |
Ms. Candace Lea Gray Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9810 Bluegrass Pkwy, Louisville, KY 40299 Phone: 502-584-9781 |
Amy Bonner, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 303 N Hurstbourne Pkwy, Suite 200, Louisville, KY 40222 Phone: 502-412-5847 |
Emily K Robbins, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1100 E Market St, Louisville, KY 40206 Phone: 502-596-1135 |
Katie Weber Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2817 Del Rio Pl Ste 109, Louisville, KY 40220 Phone: 502-548-7914 |
Mrs. Rebecca Lynn Phillips, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3414 Hastings Cir, Louisville, KY 40241 Phone: 502-426-4763 Fax: 502-426-4763 |
Jennifer Louise Wheeler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 71 Breckinridge Sq, Louisville, KY 40220 Phone: 502-640-1497 |
Megan Craddock Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3324 Frontier Trl, Louisville, KY 40220 Phone: 502-435-6316 |
Mrs. Amy Jean Gray, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1053 Eastern Pkwy, Louisville, KY 40217 Phone: 502-637-3545 Fax: 502-637-3545 |
Mrs. Kelsey Scott Norcia, MS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 7504 Westport Rd, Louisville, KY 40222 Phone: 502-736-7800 |
Katelyn Rebecca Hall, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 S Hurstbourne Pkwy Ste 213, Louisville, KY 40222 Phone: 502-353-2074 Fax: 317-520-8200 |
Kaylee Brandt, M.S. CF/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13010 Eastgate Park Way Ste 101, Louisville, KY 40223 Phone: 502-244-1210 |
Shannon Becker Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 |
Sarah Mullaney Sanders, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9810 Bluegrass Pkwy, Louisville, KY 40299 Phone: 502-584-9781 |
Elizabeth K Ragsdale, M.S., CCC-A Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 117 E Kentucky St, Louisville, KY 40203 Phone: 502-584-3573 Fax: 502-583-6364 |
Rebecca R Medley, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 982 Eastern Pkwy, Louisville, KY 40217 Phone: 502-635-6397 Fax: 502-635-1147 |
News Archive
EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe
Genzyme, a Sanofi company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for approval of LEMTRADA (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.
Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Exercise may improve cognitive function
Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition, according to two reports in the January issue of Archives of Neurology, one of the JAMA/Archives journals.
ADHD behaviors in children associated with serotonin activity and self-blame
ADHD may be caused by alterations in the serotonin neurotransmission system combined with a tendency to experience psychosocial distress. Researchers writing in BioMed Central's open access journal Behavioral and Brain Functions found that ADHD behaviors in children and adolescents were associated with interactions between low and high serotonin activity and self-blame in relation to inter-parental conflict.
Study uncovers new genetic variants linked to increased risk of testicular cancer
A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.
› Verified 8 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Podiatrists
Audiologists